$PTGX news
The latest PTGX stock news: headlines, filings, AI summaries and sentiment for $PTGX, updated around the clock.
- Johnson & Johnson Announces Positive Late-Stage Trial Results for Psoriatic Arthritis Treatment
- Protagonist Therapeutics, Inc - 10-Q Filing
- Protagonist Therapeutics Reports Q3 Earnings Beat with Significant Revenue Growth
- Protagonist Therapeutics, Inc - 8-K Filing
- FDA Approval of MIMRYLO Triggers $275M Payments for Protagonist
- Johnson & Johnson's Top Investment Among Its Biotech Holdings
- Johnson & Johnson Receives Approval in China for Oral Psoriasis Treatment
- Hedge Fund ADAR1 Capital Management Invests $36 Million in Denali Therapeutics Following FDA Approval